Genexine, Inc. logo

Genexine, Inc.

16 Marks
Corp.
First Filed:Dec 15, 2014Latest Filed:Sep 24, 2024Address:172, Magokjungang-ro, Gangseo-gu, Seoul, 07789, KR

Portfolio Overview

Registered
8(50%)
Dead
8(50%)

Top Classes

Class 5
Pharmaceuticals
12(75%)
Class 42
Software, IT Services & Scientific Research
4(25%)

TTAB Proceedings

No litigation activity

Top Firms

Loading...

Trademark Activity Timeline(2014 – 2025)

Trademark Portfolio

16 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
HYFC TECHNOLOGY
HYFC TECHNOLOGY
Service Mark
Combined
REGISTERED
Owner:
Serial:98766268
Filed:Sep 24, 2024
Classes:42
Registration:7898324
Registered:Aug 19, 2025
Goods & Services
"TECHNOLOGY"; Drug discovery services; research and development in the field of peptides for medical purposes; laboratory research services relating to pharmaceuticals; research for medical products; providing information on the testing, inspection and research of medical products; scientific research consulting services in the field of medical products
EFESA
EFESA
Trademark
Stylized
REGISTERED
Owner:
Serial:79391354
Filed:Dec 22, 2023
Classes:5
Registration:7709057
Registered:Mar 4, 2025
Goods & Services
Pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical agents affecting metabolism; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cardiovascular disease; medicines for the treatment of cardiovascular and cerebrovascular diseases; pills for dizziness symptoms treatment being pharmaceutical preparations for the treatment of dizziness; biological preparations for medical purposes being biological preparations for the treatment of anemia, kidney disease and kidney disorders; cardiovascular agents for medical purposes; drugs for medical purposes being pharmaceutical preparations for the treatment of anemia, kidney disease and kidney disorders; synthetic peptides for pharmaceutical purposes being synthetic peptides for the treatment of anemia, kidney disease and kidney disorders; pharmaceuticals being pharmaceutical preparations for the treatment of anemia, kidney disease and kidney disorders; medicines for human purposes being pharmaceutical preparations for the treatment of anemia, kidney disease and kidney disorders; anemia treatment medicines that stimulate red blood cell production being pharmaceutical preparations for the treatment of anemia; medicines to stimulate red blood cell production being pharmaceutical preparations for the treatment of anemia; pharmaceutical preparations for treatment of chronic kidney disease and anemia; biological preparations for treatment of anemia; biological preparations to stimulate red blood cell production for veterinary and medical purposes being biological preparations for the treatment of anemia; synthetic peptides for pharmaceutical and anemia treatment purposes being synthetic peptides for the treatment of anemia; synthetic peptides for pharmaceutical and kidney disease treatment purposes being synthetic peptides for the treatment of kidney disease
FIDVAXI
FIDVAXI
Trademark
Stylized
REGISTERED
Owner:
Serial:79352877
Filed:Sep 1, 2022
Classes:5
Registration:7227043
Registered:Nov 28, 2023
Goods & Services
Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely, immunomodulators; viral vaccines; pharmaceutical preparations for the treatment of viral diseases; vaccines; vaccine preparations; pharmaceutical preparations and substances for use in gynecology; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases of cancer patients; biopharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; human vaccine preparations; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for suppressing tumors
FIDVAXI
FIDVAXI
Service Mark
Stylized
REGISTERED
Owner:
Serial:79352782
Filed:Sep 1, 2022
Classes:42
Registration:7220670
Registered:Nov 21, 2023
Goods & Services
Research and development of vaccines and medicines; development of new cell therapy products for others; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; Pharmaceutical drug development services; inspection of pharmaceuticals; development of pharmaceutical preparations and medicines; laboratory research in the field of pharmaceuticals; consultancy relating to pharmaceutical research and development; pharmaceutical research and development; research on the subject of pharmaceuticals; clinical research in the field of medicine; consultancy pertaining to pharmacology; medical laboratories; medical research laboratory services; medical research laboratory services for predicting disease; medicine research; testing of pharmaceuticals
CERVICURA
CERVICURA
Trademark
Word
REGISTERED
Owner:
Serial:97235343
Filed:Jan 24, 2022
Classes:5
Registration:6990283
Registered:Feb 28, 2023
Goods & Services
DNA vaccines; preventive vaccines; pharmaceutical preparations for gene therapy; drugs for medical purposes, namely, pharmaceutical drug preparations for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of head and neck cancer; injectable pharmaceuticals for medical purposes, namely, for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; pharmaceutical preparations for immunomodulatory purposes, namely, for the regulation of immune functions; pharmaceutical preparations for the treatment of cervical cancer; pharmaceutical preparations for immunotherapy; pharmaceutical preparations for the treatment of cervical pre-cancer; vaccines; therapeutic vaccines; pharmaceutical products and preparations, namely, for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; dermatological pharmaceutical products; antiviral agent against human papilloma virus; preventive vaccines against human papilloma virus infections; pharmaceutical preparations for anticancer immunotherapy; anti-cancer preparations; pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia
HYGRASTIM
HYGRASTIM
Trademark
Word
ABANDONED
Owner:
Serial:79265618
Filed:Jun 21, 2019
Classes:5
Goods & Services
Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of short bowel syndrome; agents for treatment of diabetes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of rheumatoid arthritis; vaccines; pharmaceutical preparations for the treatment of anemia; fungicides; anti-inflammatories; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; medicated candy; pharmaceuticals; pharmaceutical preparations for the treatment of inflammatory bowel disease; pills for inflammation treatment; pharmaceutical preparations for the treatment of dwarfism; disinfectants for hygiene purposes; pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of systemic lupus erythematosus; agents for treating asthma; dermatological pharmaceutical products; antibiotic preparations; antibiotics; anti-cancer preparations; antibody fusion protein for medical treatment; blood solvent; pharmaceutical preparations for the treatment of neutropenia
PAPITROL
PAPITROL
Trademark
Word
REGISTERED
Owner:
Serial:79264599
Filed:Jun 21, 2019
Classes:5
Registration:6230670
Registered:Dec 29, 2020
Goods & Services
Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of short bowel syndrome; Pharmaceutical agents for treatment of diabetes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of rheumatoid arthritis; vaccines; pharmaceutical preparations for the treatment of anemia; fungicides; anti-inflammatories; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations for the treatment of cardiovascular disorders; medicated candy; Pharmaceutical preparations to treat HPV type 16 and/or 18 caused Precancerous Dysplasia and Cancer; pharmaceutical preparations for the treatment of inflammatory bowel disease; Pharmaceutical preparations being pills for inflammation treatment; pharmaceutical preparations for the treatment of dwarfism; disinfectants for hygiene purposes; pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of systemic lupus erythematosus; Pharmaceutical agents for treating asthma, Pharmaceutical agents for the treatment of asthma; dermatological pharmaceutical products; antibiotic preparations; antibiotics; anti-cancer preparations; Antibody fusion protein for medical treatment in the nature of pharmaceutical preparations for the treatment of HPV type 16 and/or 18 caused Precancerous Dysplasia and Cancer; blood solvent, namely, blood plasma; pharmaceutical preparations for the treatment of neutropenia
HILEUKIN-2
HILEUKIN-2
Trademark
Word
ABANDONED
Owner:
Serial:88469472
Filed:Jun 12, 2019
Classes:5
HYLEUKIN-7
HYLEUKIN-7
Trademark
Word
ABANDONED
Owner:
Serial:88469477
Filed:Jun 12, 2019
Classes:5
OPTIDART
OPTIDART
Trademark
Word
REGISTERED
Owner:
Serial:79264896
Filed:May 17, 2019
Classes:5
Registration:6599482
Registered:Dec 28, 2021
Goods & Services
Pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases; vaccines; adjuvants for use with vaccines; vaccine preparations; anti-inflammatories; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; nucleic acid sequences for medical and veterinary purposes; diagnostic preparations for medical purposes for detecting mutation in prion genes; chemical preparations for use in DNA analysis for medical purposes; reagents for use in medical genetic testing; human vaccine preparations; pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of immune system related diseases and disorders; anti-asthmatic agents, namely, pharmaceutical preparations for the treatment of asthmatic disorders; dermatological pharmaceutical products; antibiotic preparations; biological preparations, namely, antibody fusion proteins for the treatment of cancer
HYFC TECHNOLOGY
HYFC TECHNOLOGY
Trademark
Combined
CANCELLED
Owner:
Serial:79232578
Filed:Feb 28, 2018
Classes:5
Registration:5736165
Registered:Apr 30, 2019
Goods & Services
Pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases; pharmaceutical preparations for urogenital organs; pharmaceutical preparations for preventing and treating obesity; pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for wounds; pharmaceutical preparations for activating cellular function; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; Synthetic peptides for pharmaceutical purposes for the treatment of infectious diseases; Synthetic peptides for pharmaceutical purposes for treating hypertension; Synthetic peptides for pharmaceutical purposes for the prevention of osteoporosis; Synthetic peptides for pharmaceutical purposes for the treatment of hormonal disorders and the prevention of osteoporosis; Synthetic peptides for pharmaceutical purposes for the treatment of eye diseases and conditions; Synthetic peptides for pharmaceutical purposes for the treatment of multiple sclerosis; Synthetic peptides for pharmaceutical purposes for treating diabetes; Synthetic peptides for pharmaceutical purposes for affecting metabolism; Synthetic peptides for pharmaceutical purposes for regulating the immune system; Synthetic peptides for pharmaceutical purposes for the treatment of viral diseases; Synthetic peptides for pharmaceutical purposes for affecting and treating urogenital organs; Synthetic peptides for pharmaceutical purposes for preventing and treating obesity; Synthetic peptides for pharmaceutical purposes for the treatment of bone diseases; Synthetic peptides for pharmaceutical purposes for wounds; Synthetic peptides for pharmaceutical purposes for activating cellular function; Synthetic peptides for pharmaceutical purposes for affecting digestive organs; Synthetic peptides for pharmaceutical purposes for the treatment of cardiovascular disease; Synthetic peptides for pharmaceutical purposes for treating malignant tumours; Synthetic peptides for pharmaceutical purposes for the treatment and prevention of cancer; Synthetic peptides for pharmaceutical purposes for treatment of viral and infectious diseases, for the treatment of cancer; Synthetic peptides for pharmaceutical purposes for the treatment of cancer; Synthetic peptides for pharmaceutical purposes for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of auto-immune diseases; "TECHNOLOGY"
HYLEUKIN
HYLEUKIN
Trademark
Word
ABANDONED
Owner:
Serial:87696005
Filed:Nov 23, 2017
Classes:5
HYFC TECHNOLOGY
HYFC TECHNOLOGY
Service Mark
Combined
CANCELLED
Owner:
Serial:87547399
Filed:Jul 28, 2017
Classes:42
Registration:5568322
Registered:Sep 25, 2018
Goods & Services
"TECHNOLOGY"; Laboratory research services relating to pharmaceuticals; Research for medical products; Providing information on the testing, inspection, and research of medical products; Scientific research consulting services in the field of medical products; Drug discovery services; Research and development in the field of peptides for medical purposes
CERVICURA
CERVICURA
Trademark
Stylized
CANCELLED
Owner:
Serial:79166469
Filed:Apr 20, 2015
Classes:5
Registration:4893999
Registered:Feb 2, 2016
Goods & Services
DNA vaccines; Pharmaceutical products and preparations, namely, for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; vaccines; antibiotics; anti-cancer preparations; Drugs for medical purposes, namely, pharmaceutical drug preparations for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; Injectable pharmaceuticals for medical purposes, namely, for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; Cardiovascular pharmaceutical preparations for the treatment and prevention of heart and vascular diseases; Medicines for sensory organs, namely, pharmaceutical preparations for the prevention, treatment, and cure of diseases and conditions impacting the eyes, ears, nose, mouth and nervous system; Pharmaceutical preparations for digestive organs, namely, for the prevention, treatment, and cure of diseases and conditions impacting digestive organs; Dermatological pharmaceutical products; Blood solvent, namely, blood plasma, albumin, globulin, fibrinogen, thrombocyte and platelets; Pharmaceutical agents affecting metabolism; Anti-inflammatory preparations, namely, anti-inflammatory gels, ointments, salves, sprays, creams, pills, powders, granules, tablets, capsules, depots, suppository, syrup, tinctures and emulsion; Therapeutic vaccines; preventive vaccines; Pharmaceutical preparations for immunomodulatory purposes, namely, for the regulation of immune functions; Pharmaceutical preparations for the treatment of cervical cancer; Pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of cervical pre-cancer; Pharmaceutical preparations for the treatment of head and neck cancer; Pharmaceutical preparations for immunotherapy; pharmaceutical preparations for anticancer immunotherapy; Pharmaceutical preparations for gene therapy; antiviral agent against human papilloma virus; preventive vaccines against human papilloma virus infections
GENEXINE
GENEXINE
Service Mark
Word
REGISTERED
Owner:
Serial:79164375
Filed:Dec 15, 2014
Classes:42
Registration:4806220
Registered:Sep 8, 2015
Goods & Services
Research and development of vaccines and medicines; crude medicines research; research on adult diseases; bacteriological research; research on cancer; pharmaceutical products development; pharmaceutical products research; pharmaceutical products evaluation; consultancy pertaining to pharmacology; medical product testing; research for medical products; medical research; clinical trials; research and development of DNA chips; structural and functional analysis of genomes; biotechnology research; advisory services relating to biotechnology; biological research; biochemical analysis; biochemical research; research in the field of gene analysis; genetic research; testing/inspection or research on pharmaceuticals/cosmetics or food
HYFC
HYFC
Trademark
Word
ABANDONED
Owner:
Serial:79164661
Filed:Dec 15, 2014
Classes:5
Goods & Services
Pharmaceuticals; vaccines; anti-cancer preparations; antibiotics; antibiotic preparations; pills for inflammation treatment; cardiovascular pharmaceutical preparations; medicines for sensory organs; pharmaceutical preparations for digestive organs; dermatological pharmaceutical products; blood solvent; agents affecting metabolism; anti-inflammatory preparations; disinfectants for hygiene purposes; fungicides; medicated candy; agents for treatment of diabetes; asthmatic agents; immunoglobulin fusion protein agents; medicines for the treatment of neutropenia; medicines for the treatment of anemia; medicines for the treatment of dwarfism; medicines for the treatment of inflammatory bowel disease; medicines for the treatment of short-bowel syndrome; medicines for the treatment of psoriasis; medicines for the treatment of proliferative arthritis; medicines for the treatment of systemic lupus erythematosus; medicines for the treatment of cervical tumor

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.